Member Info for DiscoDividends

Taken out, as in company acquired?

Bruce, my gut tells me that also. Range between 10-20p until further announcements are made on next steps. Confirmation of IP tied up is an important one, in addition to response from regulators on further trials. Sooner the better on that front, as it will give an understanding on what cash needed to keep FUM running in the interim.

Where do we honestly think this is going from here folks. No BS.

I am reassured to see that this is some of the most constructive and objective debate I have observed on this forum pertaining to FUM for some time. I lost big time yesterday, but got out earlyish yesterday and rebought lower. Like many here, I have further digested the news and believe there is still solid commercial merit to FUM and DermaSys, albeit in a different form of commercial and regulatory pathway.

In my opinion, FUM need to beef up their commercial team and bolster the BOD with further additions with demonstrable experience in these realms. With that in place, I believe this has solid legs to progress forward IMHO. I will mobilise a buy on a further dip.

GLA

Thanks for asking, I'm keen to know also.

For it is worth, the unexpected news still has commercial merit and therefore is far from failure. I should have known to use more caution when approaching these types of events, but hey ho. I'll be having a stiff drink tonight.

The DermSys platform has proved effective here, however the focus was on MED and in that respect there is no getting away from these results being dissapointing. FUM still has a future and commercial prospects, but they will need to sharply refocus.

Kudos. Big balls. If this drops to ATL then I will revisit a buy.

Just wow...

No news released first thing. Wonder if this will be today or next few days now?

Calm before the storm folks... I think we will see some action late afternoon into Monday. Strap in! My bags are loaded. The dice is rolled. GLA

It isn't an OTC, and won't be for a while. So you are talking about reimbursement in the US through insurers. They have deep pockets and are far less price-sensitive than the European markets/payers/regulators.

The OTC switch opportunity will be further down the line, but will present an opportunity for further commercial rights for FUM.

15 days? I suspect it's more like 5 days...

Congrats sir!

No one knows what the price will do exactly. If it drops 20p prior but launches upwards after results it is almost immaterial!

Interestingly, H&L are not letting my market orders through!!

Thanks v0latility, saw that - meant to say, except for that too :-) Maybe hoping for too much for additional coverage.

Would be interested to understand what the thoughts are of other analysts and brokers out there? Liberum represent FUM.

Apologies if my explanation is not clear. Someone else can possibly translate better than I can.

No - 19 possible approval outcomes, therefore commercial possibilities. One failure option.

If we hit failure, which holds a minority percentage chance, then the market would react understandably bad. However, what the report says is that 95% chance of some form of positive outcome. 70% chance of THE MOST positive outcome.

No, it means there a total of 20 possible outcomes from the read-out. With only one of the 19 outcomes being considered a failure. The other 19 positive outcomes have various different options for commercialization - which is good.